Read an excerpt from a new book on medical technology costs and health care by Daniel Callahan, who advocates "an open discussion on what counts as good or bad choices, wise or imprudent ones, and our social obligations to our community as we make them."
Bioethics
November 6, 2009: The Aim of Health Care
September 4, 2009: Personalized Genetic Testing
Is the promise of direct-to-consumer genetic testing being oversold? What ethical and public policy concerns does selling genetic tests directly to the public raise?
March 13, 2009: Stem Cell Dilemmas
David Masci, a senior research fellow at the Pew Forum on Religion & Public Life, discusses religious, ethical, and moral perspectives on lifting federal funding limits on embryonic stem cell research.
March 6, 2009: Familial DNA Testing
Some say that without safeguards it is a slippery slope on the road to genetic surveillance. Others are convinced it will bring many more criminals to justice.
January 23, 2009: End of Life Dilemmas
One-third of Alzheimer's patients in nursing homes have feedings tubes. Their use in people who are in the final stages of dementia is a controversial and emotional ethical issue.
August 15, 2008: Animal Testing Ethics
Animal research has long been controversial. The medical benefits can be significant, although not always, and opponents argue the benefits are often outweighed by the pain and suffering inflicted on the animal.
June 6, 2008: Alzheimer’s Testing
Now, a moral dilemma facing some of the children of people who have Alzheimer's disease, for which there is, so far, no cure. If they could know that they are likely to get the disease themselves would they want to take a test if there were one that could predict that?
August 17, 2007: Genetic Enhancement
Parents want to do whatever is possible to make their children healthy. But what about going beyond health to enhancement, making kids bigger or smarter or more talented? Science is opening that door in a big way, and many ethicists debate where the line between health and enhancement should be. Kim Lawton has our story.
August 17, 2007: Michael Sandel
Read R & E producer Susan Grandis Goldstein’s June 5, 2007 interview with Michael Sandel in Washington, D.C.
August 17, 2007: Gregory Stock
Read Kim Lawton's interview with Gregory Stock, CEO of Signum Biosciences and director of the Medicine, Technology, and Society Program at the UCLA School of Medicine.















